Invention Grant
- Patent Title: FGF-18 formulation in xyloglucan gels
-
Application No.: US15105622Application Date: 2014-12-23
-
Publication No.: US10293051B2Publication Date: 2019-05-21
- Inventor: Caterina Lo Presti , Donatella Bulone , Clelia Dispenza
- Applicant: ARES TRADING S.A.
- Applicant Address: CH Aubonne
- Assignee: ARES TRADING S.A.
- Current Assignee: ARES TRADING S.A.
- Current Assignee Address: CH Aubonne
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Priority: EP13199588 20141223
- International Application: PCT/EP2014/079194 WO 20141223
- International Announcement: WO2015/097233 WO 20150702
- Main IPC: A61K47/36
- IPC: A61K47/36 ; A61K47/02 ; A61K38/18 ; A61L27/52 ; A61K9/00 ; A61L27/54
Abstract:
The invention relates to the field of pharmaceutical formulations. More particularly, it is directed to xyloglucan hydrogels comprising Fibroblast Growth Factor 18 (FGF-18) compounds and methods of producing such hydrogels. The hydrogels of the invention can be used, once formed in situ, for the treatment of cartilage disorders such as osteoarthritis or cartilage injury.
Public/Granted literature
- US20160317668A1 FGF-18 FORMULATION IN XYLOGLUCAN GELS Public/Granted day:2016-11-03
Information query
